Skip to main content
. 2021 Nov 2;74(Suppl 1):S54–S63. doi: 10.1093/cid/ciab822

Table 2.

Effect Modification by Sex of the Association Between Invasive Group B Streptococcus Disease and Mortality.

Single Reference Category Analyses Stratified Analyses
Cohorts Mortality Rate per 1000 Person-Years HR (95% CI) for iGBS Using a Common Reference Group Effect Modification on Additive Scale (Interaction Contrast [95% CI]); AP [%] HR (95% CI) for iGBS Within Strata of Sex Effect Modification on Multiplicative Scale (P Value of GBS × Sex)
Denmark
  0–89 days
 GBS–/Girls 73.7 (60.1–87.4) 1.00 (reference) 1.00 (reference)
 GBS+/Girls 98.1 (48.4–147.7) 0.87 (0.51–1.49) 0.89 (0.52–1.53)
 GBS–/Boys 63.5 (52.1–74.9) 1.04 (0.81–1.35) 1.00 (reference)
 GBS+/Boys 100.6 (55.4–145.9) 1.16 (0.71–1.88) 12.8 (–56.7 to 82.2); 12.7% 1.08 (0.67–1.76) P = .52
  0–5 years
 GBS–/Girls 4.4 (3.7–5.2) 1.00 (reference) 1.00 (reference)
 GBS+/Girls 6.5 (3.6–9.4) 0.97 (0.60–1.57) 1.00 (0.62–1.62)
 GBS–/Boys 3.8 (3.1–4.4) 1.01 (0.80–1.29) 1.00 (reference)
 GBS+/Boys 5.3 (2.9–7.6) 1.01 (0.62–1.63) –0.6 (–4.5 to 3.3); NA 0.97 (0.60–1.57) P = .90
The Netherlands
  0–89 days
 GBS–/Girls 71.7 (52.4–91.0) 1.00 (reference) 1.00 (reference)
 GBS+/Girls 340.7 (204.4–477.0) 4.33 (2.67–7.02) 4.33 (2.67–7.01)
 GBS–/Boys 72.0 (54.8–89.3) 1.24 (0.87–1.79) 1.00 (reference)
 GBS+/Boys 302.7 (188.5–416.8) 4.76 (2.99–7.57) –38.3 (–218.0 to 141.4); NA 3.82 (2.44–5.97) P = .71
  0–5 years
 GBS–/Girls 4.6 (3.4–5.8) 1.00 (reference) 1.00 (reference)
 GBS+/Girls 20.2 (12.1–28.3) 3.81 (2.37–6.14) 3.81 (2.36–6.13)
 GBS–/Boys 4.6 (3.6–5.7) 1.17 (0.83–1.65) 1.00 (reference)
 GBS+/Boys 18.8 (12.0–25.7) 4.85 (3.10–7.58) –1.4 (–12.1 to 9.3); NA 4.14 (2.70–6.36) P = .80

HRs are adjusted for matching variables (birth year, gestational age). Due to absence of cases in the extreme preterm age category (<28 weeks), the preterm age categories were merged (<37 weeks) for adjustment purposes.

Abbreviations: AP, attributable proportion; CI, confidence interval; HR, hazard ratio; iGBS, invasive group B Streptococcus disease; NA, not applicable.